Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Relative Survival (excess mortality) of individuals diagnosed with lung cancer in the National Lung Screening Trial.

Principal Investigator
Name
Martin Tammemagi
Degrees
DVM; MSc; PhD
Institution
Henry Ford Health System
Position Title
Professor of Epidemiology
Email
About this CDAS Project
Study
NLST (Learn more about this study)
Project ID
201110-0019
Initial CDAS Request Approval
Oct 25, 2011
Title
Relative Survival (excess mortality) of individuals diagnosed with lung cancer in the National Lung Screening Trial.
Summary
The general aim of this study is to evaluate the relative survival of individuals diagnosed with lung cancer, corrected for the effect of other causes of death by utilizing patients’ expected “survival” given National age-, sex-, race/ethnicity-, and year-specific mortality rates.